Literature DB >> 26424102

A HEALth Promotion and STRESS Management Program (HEAL-STRESS study) for prehypertensive and hypertensive patients: a quasi-experimental study in Greece.

C Darviri1, A K Artemiadis1, A Protogerou2, P Soldatos1, C Kranioutou1, S Vasdekis1, L Varvogli1, E Nasothimiou2, E Vasilopoulou1, E Karantzi1, A Linardatou1, M Michou1, G P Chrousos1.   

Abstract

Current hypertension guidelines advocate strategies encouraging healthy lifestyle behaviours. So far, there is a paucity of studies for the efficacy of such multifaceted programmes. The aim of this study is to investigate the efficacy of an 8-week health-promotion programme for lowering blood pressure (BP) in prehypertensive and hypertensive patients in the community. This was a quasi-experimental study using wait-list controls of 548 patients. The intervention group was administered with an 8-week health-promotion intervention. Measurements included home BP, smoking, body mass index (BMI), perceived stress, depression, anxiety and Health Locus of Control. After adjusting for confounders, the intervention group had a significant reduction in both systolic BP (SBP; mean -2.62 mm Hg, 95% confidence interval (CI): -1.29 to -3.96) and diastolic BP (DBP; mean -1.0, 95% CI: -0.93 to -1.9) compared with controls. In all, 14.9% of patients in the intervention group had >10 mm Hg reduction in SBP vs 4.4% in the control group (P<0.001, numbers needed to treat (NNT)=10). With regards to DBP, 21.7% of patients in the intervention group had >5 mm Hg reduction vs 12.5% in the control group (P=0.01, NNT=11). In terms of effect size, moderate-to-large improvements of BMI, perceived stress, anxiety, depression, external and chance Health Locus of Control were recorded. Changes in SBP and DBP were attributed to BMI and depressive symptom reductions, respectively. Comprehensive non-pharmaceutical programmes for BP management are strongly encouraged. Their long-term benefits on cardiovascular morbidity and mortality remain to be established by future research.

Entities:  

Mesh:

Year:  2015        PMID: 26424102     DOI: 10.1038/jhh.2015.99

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  30 in total

Review 1.  RESPeRATE: the role of paced breathing in hypertension treatment.

Authors:  Relu Cernes; Reuven Zimlichman
Journal:  J Am Soc Hypertens       Date:  2014-10-16

Review 2.  Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work.

Authors:  Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez
Journal:  Biol Psychol       Date:  2011-07-07       Impact factor: 3.251

3.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

Authors:  Edgar R Miller; Thomas P Erlinger; Deborah R Young; Megan Jehn; Jeanne Charleston; Donna Rhodes; Sharmeel K Wasan; Lawrence J Appel
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

5.  Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension.

Authors:  Efthimia G Nasothimiou; Dimitrios Tzamouranis; Vagia Rarra; Leonidas G Roussias; George S Stergiou
Journal:  Hypertens Res       Date:  2012-02-23       Impact factor: 3.872

Review 6.  Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis.

Authors:  Maxwell V Rainforth; Robert H Schneider; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; James W Anderson
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

7.  Effects of exposure to the suffering of unknown persons on health-related cognitions, and the role of mood.

Authors:  Evangelos C Karademas
Journal:  Health (London)       Date:  2009-09

Review 8.  Clinical effectiveness of stress-reduction techniques in patients with hypertension: systematic review and meta-analysis.

Authors:  Eva Nagele; Klaus Jeitler; Karl Horvath; Thomas Semlitsch; Nicole Posch; Kirsten H Herrmann; Ulrich Grouven; Tatjana Hermanns; Lars G Hemkens; Andrea Siebenhofer
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844

9.  Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study.

Authors:  Aris D Efstratopoulos; Sofia M Voyaki; Athanasios A Baltas; Filippos A Vratsistas; Dimitrios-Eteoklis P Kirlas; John T Kontoyannis; John G Sakellariou; George B Triantaphyllou; Gregorios A Alokrios; Dimitrios N Lianas; Emanuel A Vasilakis; Kyriakos N Fotiadis; Evangelia E Kastritsea
Journal:  Am J Hypertens       Date:  2006-01       Impact factor: 2.689

Review 10.  Lifestyle factors in hypertension drug research: systematic analysis of articles in a leading cochrane report.

Authors:  Dan E Wilson; Tashina Van Vlack; Brendin P Schievink; Eric B Doak; Jason S Shane; Elizabeth Dean
Journal:  Int J Hypertens       Date:  2014-01-28       Impact factor: 2.420

View more
  3 in total

1.  Stress, adherence, and blood pressure control: A baseline examination of Black women with hypertension participating in the SisterTalk II intervention.

Authors:  Augustine W Kang; Akilah Dulin; Sarah Nadimpalli; Patricia M Risica
Journal:  Prev Med Rep       Date:  2018-08-03

2.  Interventions in hypertension: systematic review and meta-analysis of natural and quasi-experiments.

Authors:  Tong Xia; Fan Zhao; Roch A Nianogo
Journal:  Clin Hypertens       Date:  2022-05-01

3.  Factors Associated with Antihypertensive Medication Non-Adherence: A Cross-Sectional Study Among Lebanese Hypertensive Adults.

Authors:  Hanine Abbas; Mazen Kurdi; Frank de Vries; Hein A W van Onzenoort; Johanna H M Driessen; Myriam Watfa; Rita Karam
Journal:  Patient Prefer Adherence       Date:  2020-04-01       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.